Laboratory Testing for Cardiac Work-Up in an 18-Year-Old Female with Tachycardia
For an 18-year-old female presenting with tachycardia, order electrolyte screening (particularly potassium, magnesium, calcium), thyroid function tests (TSH, free T4), complete blood count, and consider cardiac biomarkers (troponin, BNP/NT-proBNP) only if structural heart disease or heart failure is suspected based on clinical presentation or ECG findings.
Initial Laboratory Evaluation
The primary laboratory focus should be on identifying reversible causes of tachycardia rather than routine cardiac biomarker screening 1:
Essential Laboratory Tests
Electrolyte panel: Hypokalemia, hypomagnesemia, and hypocalcemia can precipitate arrhythmias and must be identified. This is specifically recommended when prolonged QTc is present on ECG 2
Thyroid function studies (TSH, free T4): Hyperthyroidism is a critical reversible cause of tachycardia in young adults. Guidelines emphasize screening for thyroid disease as a precipitating factor 1. Recent data shows thyroid studies are the most commonly ordered tests (10.5% of cases) in pediatric/young adult SVT presentations, though abnormal results occur in less than 25% 3
Complete blood count: Anemia is a common physiologic cause of compensatory sinus tachycardia 4
Renal and hepatic function: Baseline assessment recommended for all patients with arrhythmias 5
Conditional Laboratory Tests
Cardiac biomarkers should NOT be routinely ordered unless specific clinical features suggest structural heart disease:
- Troponin I: Only if myocarditis, acute coronary syndrome, or myocardial disease suspected
- BNP or NT-proBNP: Only if heart failure or cardiomyopathy suspected clinically. These may be elevated in persistent tachycardia but normalize after rhythm conversion 5
Toxicology screening: Consider only if history suggests substance use (caffeine excess, stimulants, recreational drugs, alcohol) 1. Data shows toxicology testing is infrequently performed (1.6% of cases) 3
Inflammatory markers: Not routinely indicated unless myocarditis or pericarditis suspected clinically 2
Critical Context: The ECG Drives the Work-Up
The laboratory evaluation is secondary to ECG interpretation. A 12-lead ECG must be obtained first 1, 5, 6. The ECG findings determine whether additional cardiac-specific testing is needed:
If sinus tachycardia (rate >100 bpm, age-adjusted upper limit ~200 bpm): Focus labs on identifying physiologic stressors (infection, fever, dehydration, anemia, hyperthyroidism) 4
If supraventricular tachycardia (paroxysmal, regular): Electrolytes and thyroid studies are the priority; cardiac biomarkers generally unnecessary in structurally normal hearts 1
If ECG abnormalities suggesting structural disease (T-wave inversions, pathologic Q waves, pre-excitation): Then echocardiography becomes essential, and cardiac biomarkers may be warranted 2, 1
Common Pitfalls to Avoid
Over-ordering cardiac biomarkers: In young patients without structural heart disease, troponin and BNP testing has low yield and may lead to unnecessary downstream testing 3
Missing reversible causes: Failure to check thyroid function and electrolytes misses easily treatable etiologies
Delaying ECG for laboratory results: The ECG should never be delayed for laboratory testing 4
Assuming laboratory testing replaces imaging: If sustained SVT is documented, echocardiography is recommended to exclude structural heart disease, which cannot be detected by labs alone 1
Age-Specific Considerations
At 18 years old, this patient falls into the young adult category where:
- Structural heart disease is less common but must still be excluded 1
- Supraventricular arrhythmias often occur in the absence of detectable heart disease 1
- Coronary artery disease is extremely unlikely (becomes relevant ≥30 years) 2
- Congenital conditions, channelopathies, and cardiomyopathies are the primary structural concerns
The laboratory work-up should be targeted and evidence-based rather than reflexive, with electrolytes and thyroid function as the cornerstone tests, reserving cardiac biomarkers for cases with clinical or ECG evidence suggesting myocardial involvement 1, 3.